Atossa Genetics Inc. announced the formation of a strategic advisory board comprised of prominent executives from the pharmaceutical industry. The company has named former Pfizer executive, bestselling author and thought leader, Bob Miglani, and Dr. Joseph M. Chalil, formerly an executive at Boehringer Ingelheim, to the strategic advisory board. Bob Miglani: Bob Miglani worked at Pfizer Inc. in roles of increasing responsibility over the course of 23 years, spanning many functions including sales, marketing research, pricing and reimbursement, communications, patient advocacy, market access, partnership development, strategy and external medical affairs. Dr. Joseph Chalil: Prof. Joseph M. Chalil, MD, MBA, FACHE, is an expert in Pharmaceutical and Biotechnology Clinical Development and Medical Affairs with over 17 years experience in the field. Dr. Chalil is a member of Healthcare Advisory Board and an Adjunct Professor at Nova Southeastern University in Florida.